Our analysis revealed that CAP1 was over-expressed in bladder, lung, lymphoma, melanoma, head-neck, pancreatic cancers, but was under-expressed in breast and leukemia cancers as compared to that in normal tissue (Table 2, Figure 2, Supplementary Figures 1–3) [25–39]. Here, CAP1 is linked to lymphoma.